Rocket Pharmaceuticals Inc — Dividend History & Yield (NASDAQ:RCKT) | MetaTrader

Open full chart

Financials

Overview Relevé Statistics Dividends

Quarterly Annual

Dividends per share —————— — Dividend yield % —————— — Payout ratio % —————— —

Nouvelles

RCKT's Q4 Loss Narrower Than Estimated, Pipeline in Focus

Rocket Pharmaceuticals, Inc. (RCKT) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Rocket Pharmaceuticals: Upside On LAD-I Approval And Amended Danon Program

Helmerich and Payne, Invivyd, Home Depot et d'autres grandes actions baissent lors de la séance de préouverture du marché de mardi | Benzinga France

Helmerich and Payne, Invivyd, Home Depot And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Alpha Technology Group (NASDAQ:ATGL), Fulcrum Therapeutics (NASDAQ:FULC)

L'approche rigide de la FDA ajoute de l'incertitude au parcours accéléré de uniQure pour la thérapie génique de la maladie de Huntington | Benzinga France

RCKT Stock Up as FDA Accepts Resubmitted BLA for Gene Therapy

Acceptation par la FDA de la demande de thérapie génique principale de Rocket Pharmaceuticals rétablit l'élan pour les actions | Benzinga France

Wells Fargo, Walmart Lead Tuesday’s Market Cap Stock Movers

Goldman Sachs, Avago tech lead market cap stock movers on Tuesday

FDA Acceptance Of Rocket Pharmaceuticals' Lead Gene Therapy Application Reestablishes Momentum For Stock - Rocket Pharmaceuticals (NASDAQ:RCKT)

FDA accepts Rocket Pharmaceuticals’ gene therapy BLA for rare disease